How much funding has AdvanCell raised?

AdvanCell has raised $112.0M in total funding, most recently a Series C round.

Where is AdvanCell headquartered?

AdvanCell is headquartered in Sydney, Australia.

What industry is AdvanCell in?

AdvanCell operates in Biotech, Healthcare.

AdvanCell

Changing the Course of Cancer Treatment

Sydney, Australia · Founded 2019 · $112.0M raised

Biotech

Healthcare

Headquarters: Sydney
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: advancell.com.au
Total Funding: $112.0M
Last Round: $112.0M Series CFeb 2025
Rounds: 1

About

AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer using lead-212 (212Pb). Headquartered in Sydney, Australia with a growing US presence, the company operates a vertically integrated platform for manufacturing and delivering 212Pb-based therapies, with a lead program targeting PSMA for prostate cancer.

Summary

AdvanCell is a Biotech company based in Sydney, Australia, founded in 2019. It has raised $112.0M in total across 1 round, most recently a $112.0M Series C round in Feb 2025.